Literature DB >> 15329339

Skeletal muscle atrophy leads to loss and dysfunction of muscle precursor cells.

Patrick O Mitchell1, Grace K Pavlath.   

Abstract

Atrophy of skeletal muscle leads to decreases in myofiber size and nuclear number; however, the effects of atrophic conditions on muscle precursor cells (MPC) are largely unknown. MPC lie outside myofibers and represent the main source of additional myonuclei necessary for muscle growth and repair. In the present study, we examined the properties of MPC after hindlimb suspension (HS)-induced atrophy and subsequent recovery of the mouse hindlimb muscles. We demonstrated that the number of MPC in atrophied muscles was decreased. RT-PCR analysis of cells isolated from atrophied muscles indicated that several mRNA characteristic of the myogenic program in MPC were absent. Cells isolated from atrophied muscles failed to properly proliferate and undergo differentiation into multinucleated myotubes. Thus atrophy led to a decrease in MPC and caused dysfunction in those MPC that remained. Upon regrowth of the atrophied muscles, these deleterious effects were reversed. Our data suggest that preventing loss or dysfunction of MPC may be a new pharmacological target during muscle atrophy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15329339     DOI: 10.1152/ajpcell.00292.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  47 in total

Review 1.  Are human and mouse satellite cells really the same?

Authors:  Luisa Boldrin; Francesco Muntoni; Jennifer E Morgan
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

2.  Pharyngeal Satellite Cells Undergo Myogenesis Under Basal Conditions and Are Required for Pharyngeal Muscle Maintenance.

Authors:  Matthew E Randolph; Brittany L Phillips; Hyo-Jung Choo; Katherine E Vest; Yandery Vera; Grace K Pavlath
Journal:  Stem Cells       Date:  2015-12       Impact factor: 6.277

3.  Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice.

Authors:  Joseph M McClung; Timothy J McCord; Sehoon Keum; Soraya Johnson; Brian H Annex; Douglas A Marchuk; Christopher D Kontos
Journal:  Am J Pathol       Date:  2012-03-21       Impact factor: 4.307

4.  Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.

Authors:  Wei A He; Federica Calore; Priya Londhe; Alessandro Canella; Denis C Guttridge; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

Review 5.  Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

Authors:  Erin E Talbert; Denis C Guttridge
Journal:  Semin Cell Dev Biol       Date:  2015-09-16       Impact factor: 7.727

6.  Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.

Authors:  Patrick O Mitchell; David M Guidot
Journal:  Am J Respir Crit Care Med       Date:  2007-08-23       Impact factor: 21.405

7.  An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure.

Authors:  Tadashi Yoshida; Patrice Delafontaine
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

8.  Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.

Authors:  Liping Zhang; Xiaonan H Wang; Huiling Wang; Jie Du; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

9.  How is the balance between protein synthesis and degradation achieved?

Authors:  Stephen Rothman
Journal:  Theor Biol Med Model       Date:  2010-06-23       Impact factor: 2.432

10.  Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.

Authors:  Fabio Penna; Domiziana Costamagna; Alessandro Fanzani; Gabriella Bonelli; Francesco M Baccino; Paola Costelli
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.